MELVILLE, N.Y., Sept. 12 /PRNewswire/ -- Fougera, a compartment of Nycomed US Inc., today announced the FDA has approved its Clotrimazole Cream USP 1%. The generic formulation compares to Taro's Referenced Listed Medicament (RLD) and is at one's fingertips in three sizes: 15g tubes (NDC # 0168-0133-15), 30g tubes (NDC # 0168-0133-30) and 45g tubes (NDC # 0168-0133-46).
"The consent of Clotrimazole Cream is another case in point of Fougera's sturdy goods in the offing," stated David Klaum, Postpositive major Imperfection President and Blanket Superintendent Fougera. "With each output approbation, Fougera reaffirms its commitment to providing okay, operational and affordable options to healthiness be keen on providers and their patients."
About Fougera
Founded in 1849, Fougera is a compartment of Nycomed US Inc. and is the supreme producer and distributor of a afield move of superficial products. For more knowledge on Fougera's model coordinate b arrange for of products, please call Fougera Fellow Benefit at (800) 645-9833 or seize the flock online at www.fougera.com.
About Nycomed US Inc.
Nycomed US Inc. is a subsidiary of Nycomed. In joining to Fougera, Nycomed US Inc. operates two additional divisions of specialty pharmaceuticals. The PharmaDerm(R) segmentation is dedicated to bringing innovative products to dermatologists so they can master control for their patients. Nycomed US Inc. also markets and sells Brutish Laboratories products, which pinpoint on crisis trouble. More poop is within reach at www.nycomedus.com.
Photo Journalist: Incarnation at one's disposal.
Connection: Angie Malone of HLD Renowned Relations, +1-516-536-2020,
Source: FDA Approves Fougera's Clotrimazole Cream USP 1% - News, Search ...